• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

special purpose acquisition company

ice skate on the ice
Biotech

Minovia skates SPAC-wards into public market

The Israeli biotech is planning to merge with publicly listed Launch One Acquisition.
Gabrielle Masson Jun 25, 2025 10:33am
SPAC special purpose acquisition company

German cancer antibody biotech eyes SPAC as route to Nasdaq

Apr 23, 2025 6:09am
SPAC special purpose acquisition company

BridgeBio's cancer spinout backs SPAC as path to Nasdaq

Feb 28, 2025 9:25am
SPAC special purpose acquisition company

Medera plans SPAC merger to advance cardiac gene therapies

Sep 5, 2024 10:50am
metronome tempo pace

Adagio Medical picks up the tempo with $128M SPAC deal

Feb 15, 2024 1:40pm
Nasdaq

Abpro inks SPAC deal to fund bispecific R&D years after axed IPO

Sep 22, 2023 9:20am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings